MétaCan
Menu
Back to cohort

Sodium-glucose Cotransporter-2 Inhibitor Initiation and Incident Dementia in Heart Failure With Diabetes: A Population-based Cohort Study

2025· article· en· W4412788713 on OpenAlexafffund
Che‐Yuan Wu, Abhinav Sharma, Jodi D. Edwards, Peter P. Liu, C Fangyun Wu, Sho Podolsky, Moira K. Kapral, Krista L. Lanctôt, Bradley J. MacIntosh, Hugo Cogo‐Moreira, Baiju R. Shah, Walter Swardfager

Bibliographic record

VenueJournal of Cardiac Failure · 2025
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsToronto General HospitalUniversity Health NetworkOntario Brain InstituteUniversity of OttawaInstitute for Clinical Evaluative SciencesMcGill UniversitySunnybrook Health Science CentreMcGill University Health Centre
FundersCanadian Institutes of Health ResearchHealth CanadaNovo NordiskUniversity of TorontoCanada First Research Excellence FundCanada Research ChairsEuropean Society of CardiologyOntario Ministry of Health and Long-Term CareTemerty Faculty of Medicine, University of TorontoCanada Excellence Research Chairs, Government of CanadaFondation Brain CanadaCanadian Cardiovascular SocietyHeart and Stroke Foundation of CanadaInstitute for Clinical Evaluative SciencesMinistry of Colleges and UniversitiesAlzheimer's Drug Discovery FoundationAlberta Innovates - Health SolutionsMinistry of Health, Ontario
KeywordsMedicineDementiaDiabetes mellitusCohortCotransporterInternal medicineHeart failureCohort studyPopulationSodiumEndocrinologyDiseaseEnvironmental health

Abstract

fetched live from OpenAlex

BACKGROUND: Heart failure often coexists with important dementia-risk factors, such as diabetes, atrial fibrillation and hypertension. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been associated with a lower dementia risk in general diabetes populations, but evidence is limited, specifically in heart failure with comorbid diabetes. OBJECTIVE: To investigate the association of SGLT2 inhibitors with incident dementia in people with heart failure and diabetes. METHODS: This target trial emulation cohort study used linkable administrative databases from Ontario, Canada. New users of SGLT2 inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors aged ≥ 66 years with diabetes and heart failure (July 2016-December 2020) entered this cohort. A 180-day lag time was implemented to mitigate reverse causality. The primary analysis used an intention-to-treat exposure definition. Cause-specific hazard ratios (HRs), with death as a competing risk, were estimated by using Cox models with propensity-score fine stratification weights. Weighted incidence-rate differences (IRDs) per 1000 person-years were also estimated. RESULTS: Among 4402 SGLT2 inhibitor and 6319 DPP4 inhibitor new users, over a median follow-up of 3.95 years from treatment initiation, SGLT2 inhibitor vs DPP4 inhibitor initiation was associated with lower dementia risk (HR 0.73, 95% confidence interval [CI] 0.60-0.87; IRD -8.1, 95% CI -12.7 to -3.5). The secondary as-treated analysis showed greater risk reduction (HR 0.53, 95% CI 0.39-0.70; IRD -14.2, 95% CI -20.1 to -8.4) than the primary intention-to-treat analysis. CONCLUSIONS: SGLT2 inhibitor initiation was associated with dementia risk reduction in heart failure and diabetes, a population at a high risk of developing dementia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.026
Threshold uncertainty score0.051

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.002
Science and technology studies0.0020.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.234
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes2
Has abstractno

Explore more

Same venueJournal of Cardiac FailureSame topicDiabetes Treatment and ManagementFrench-language works237,207